Every recall we track for InvaGen Pharmaceuticals, Inc. — 11 in all, from 2018–2023 — plus the complaints and injury reports the public filed about them. 3 are rated “stop using now”.
Recalls on record by year — 11 drug.
InvaGen Pharmaceuticals recalls Vigabatrin oral solution due to risk of powder leaking from pouches. This medication is prescription-only and may cause ineffective treatment if powder leaks.
InvaGen Pharmaceuticals recalls 600mg Gabapentin tablets due to impurity failure in long-term stability testing. Affected lots may pose risks if stored beyond expiration.
InvaGen Pharmaceuticals recalls Testosterone Topical Solution 30mg per pump due to defective container that may affect dose delivery. Affected units have NDC 69097-363-44, lots GH80480/80481.
InvaGen Pharmaceuticals recalls testosterone cypionate injections with particulate matter. Affected lots manufactured in India and shipped to US. Stop using immediately if you have the recalled product.
InvaGen Pharmaceuticals recalls 10 mg Amlodipine Besylate tablets due to subpotent drug quality. This means the medication may not be as effective as labeled, potentially requiring higher doses for treatment.
11 recalls from InvaGen Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2018–2023.
InvaGen Pharmaceuticals, Inc. recalls Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen, dated Nov 17, 2023. Every InvaGen Pharmaceuticals, Inc. recall is listed on this page, newest first.
The most common reasons on record: Presence of Particulate Matter. (3); Failed Dissolution Specifications; during stability testing (2).
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
